Targeted playtime boosts fight against dementia
Zurich/Schindellegi SZ - Cognitive motor training increases attention span, concentration, memory and orientation in people suffering from dementia. These findings are the result of work conducted by ...
Skribble enables digital signing in Zug
Zurich/Zug – Residents of Zug are now able to request documents from the town via the eZug app and receive them directly on their cell phones. Legally valid electronic contract signatures are also pos...
Investors give QUMEA 1.8 million Swiss francs
Solothurn - QUMEA has received start-up financing amounting to 1.8 million Swiss francs from investors. The start-up’s AI sensor technology enables improved service for persons requiring care. A three...
Test phase 2 for COVID 19 drugs
Schlieren ZH – The drug candidate ensovibep developed by Molecular Partners has been administered to a first patient with symptomatic COVID-19 disease in a clinical Phase 2 trial. Authorization might ...
Futurae raises investment of 5 million francs
Zurich – Futurae Technologies AG has received additional capital of 5 million Swiss francs from new and existing investors. The customer authentication specialist will use this to extend its B2B platf...
Zurich is one of the top start-up hubs
Trento – In 2020, Zurich became more attractive to start-up founders. As recently revealed by the Startup Heatmap Europe Report, which ranks the most popular start-up locations in Europe, Zurich has j...
Ticino is becoming a biotech hub
A dynamic biotech scene is taking root in the south of the Greater Zurich Area. It acts as a bridge to Italy and has impressive global ties,, which is a core characteristic of biotechnology in Switzer...
EMS-Chemie invests in Domat/Ems site
Domat/Ems GR - EMS-Chemie wants to increase capacity at its Domat/Ems location by 70 percent. To do so, it is investing 300 million Swiss francs over the next five years. Expansion started on Wednesda...
Technology to test medicinal product efficacy
Schlieren ZH – The biotech company InSphero and PharmaNest have developed a technology that can be used to test the efficacy of medicinal products. It uses artificial intelligence among other things a...
Contact us
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?
info@greaterzuricharea.com